Stadion Money Management’s iShares Biotechnology ETF IBB Stock Holding History

Stadion Money Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-200,879	Closed	-$27.5M	–	82
2020 Q2	$27.5M	Buy	+200,879	New	+$25.6M	1.12%	18
2020 Q1	–	Sell	-224,885	Closed	-$27.1M	–	74
2019 Q4	$27.1M	Buy	+224,885	New	+$25.1M	0.97%	22
2014 Q4	–	Sell	-106,845	Closed	-$9.74M	–	120
2014 Q3	$9.74M	Buy	+106,845	New	+$9.38M	0.41%	20
2013 Q4	–	Sell	-72,861	Closed	-$5.09M	–	109
2013 Q3	$5.09M	Buy	+72,861	New	+$4.77M	0.1%	38

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Stadion Money Management's IBB Position: Q3 2020 in Review

Stadion Money Management sold out of iShares Biotechnology ETF (IBB) in Q3 2020, closing a stake of 200,879 shares — an estimated $27.5M sold.

Stadion Money Management first reported a position in IBB in Q3 2013 and held it in 4 quarters. The position peaked at $27.5M in Q2 2020. 784 funds tracked by Wall St. Rank hold IBB as of Q3 2020.

Stadion Money Management reported no remaining iShares Biotechnology ETF position as of Q3 2020 after selling out during the quarter.
Stadion Money Management sold 200,879 iShares Biotechnology ETF shares in Q3 2020, an estimated $27.5M.
Stadion Money Management first reported a position in iShares Biotechnology ETF in Q3 2013 and held it in 4 quarters.
Stadion Money Management's iShares Biotechnology ETF position peaked at $27.5M in Q2 2020.
784 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2020.

Based on Stadion Money Management's 13F filing for Q3 2020, filed 16 Nov 2020.